Order results by:
| Issue | Title | |
| Vol 4, No 4 (2008) | CARDIOVASCULAR EVENT RISK REDUCTION WITH MEDICINES: DATA OF EVIDENCE BASED MEDICINE AND RECOMMENDATIONS TO PRACTITIONERS | Abstract similar documents |
| S. Y. Martsevich | ||
| "... Cardiovascular event risk reduction with medicines is discussed in the article. The role ..." | ||
| Vol 15, No 2 (2019) | Cardiovascular medicine prices as an indicator of access to medicines and their rational use | Abstract similar documents |
| C M. Razzakova, L. E. Ziganshina | ||
| "... trend of price reduction for generic products relative to reference prices for cardiovascular medicines ..." | ||
| Vol 16, No 6 (2020) | Monitoring Cardiovascular Medicine Prices as a Tool for Analyzing the Effectiveness of Government Intervetions to Ensure Access to Medicines at the Regional Level | Abstract similar documents |
| C. M. Razzakova, L. E. Ziganshina | ||
| "... cardiovascular medicines became affordable. In the private sector, there was a reduction in the prices of generic ..." | ||
| Vol 6, No 5 (2010) | FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| A. O. Shevchenko, O. P. Shevchenko | ||
| "... to more effective blood pressure control, organoprotection improvement and side events risk reduction ..." | ||
| Vol 4, No 5 (2008) | CRESTOR SHOWN SIGNIFICANT REDUCTION OF CARDIOVASCULAR RISK IN A LARGE CLINICAL TRIAL | Abstract similar documents |
| статья Редакционная | ||
| "... Journal of Medicine. ..." | ||
| Vol 6, No 6 (2010) | THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina | ||
| "... concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases ..." | ||
| Vol 9, No 5 (2013) | THE ASSESSMENT AND REDUCTION OF CARDIAC EVENTS RISK IN NONCARDIAC OPERATIONS: IS THERE A NEED FOR REVIEW OF RECOMMENDATIONS? | Abstract similar documents |
| A. N. Sumin | ||
| "... irregularities in their conduct. It makes to have a new look at the problem of perioperative medicine, to rethink ..." | ||
| Vol 13, No 2 (2017) | FALLING OF SENILE AGE PATIENT AS AN ADVERSE EVENT ASSOCIATED WITH THE USE OF MEDICINES: CASE REPORT | Abstract similar documents |
| E. S. Ilina, O. T. Bogova, S. V. Gorbatenkova, D. A. Sychev | ||
| "... взаимодействием лекарственных средств (по шкале Horn-Hansten). ..." | ||
| Vol 12, No 3 (2016) | ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER) | Abstract PDF (Eng) similar documents |
| Yu. V. Lukina, N. A. Dmitrieva, A. V. Zakharova, A. V. Zagrebelnyy, N. P. Kutishenko, S. Yu. Martsevich | ||
| "... Adverse events (As) of medicines are becoming a more serious problem of health care and society ..." | ||
| Vol 10, No 5 (2014) | STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... modification of cardiovascular complications in the perioperative period. Particular attention has recently ..." | ||
| Vol 9, No 4 (2013) | VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... The problem of varenicline use in patients with cardiovascular diseases is discussed. Results ..." | ||
| Vol 8, No 2 (2012) | ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... of acetylsalicylic acid (ASA) in primary and secondary prevention of atherothrombotic events. Studies on the safety ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... Aim. To evaluate the availability and affordability of medicines used to treat of cardiovascular ..." | ||
| Vol 6, No 5 (2010) | LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? | Abstract similar documents |
| I. V. Zhirov | ||
| "... with cardiovascular diseases are presented. The main practical ways to reduce the possible gastrointestinal ..." | ||
| Vol 1, No 1 (2005) | TOBACCO DEPENDENCE TREATMENT WITH NICOTINE REPLACEMENT THERAPY AS ONE OF THE METHODS FOR CARDIOVASCULAR DISEASE RISK REDUCTION | Abstract similar documents |
| O. V. Vikhireva, S. A. Shalnova, A. D. Deev | ||
| "... to quit smoking. To assess expected reduction of cardiovascular disease (CVD) and total mortality relative ..." | ||
| Vol 3, No 1 (2007) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE | Abstract similar documents |
| S. Y. Martsevich | ||
| "... on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists in modern ..." | ||
| Vol 14, No 6 (2018) | The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial | Abstract PDF (Eng) similar documents |
| Yu. A. Karpov | ||
| "... receiving high-intensity statin therapy, the risk of recurrent ischemic cardiovascular events was lower ..." | ||
| Vol 21, No 1 (2025) | Assessment of self-treatment in terms of inappropriate prescribing registry | Abstract similar documents |
| S. Yu. Martsevich, V. V. Tsaregorodtseva, N. P. Kutishenko, Yu. V. Lukina, A. V. Zagrebelnyi, I. V. Mihailova, O. M. Drapkina | ||
| "... with cardiovascular diseases within the Chuvashia Inappropriate Prescribing Study (CHIP) Registry. Material ..." | ||
| Vol 19, No 3 (2023) | Polypharmacy: definition, impact on outcomes, need for correction | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, O. M. Drapkina | ||
| "... для этого понятия до сих пор не сформированы, но считается, что это назначение 5 и более лекарственных ..." | ||
| Vol 9, No 1 (2013) | THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE | Abstract similar documents |
| M. V. Lebedeva, V. D. Beketov, N. V. Maltsev, M. E. Safarova | ||
| "... and prevention of fatal and non-fatal cardiovascular events are presented. ..." | ||
| Vol 17, No 4 (2021) | The Questionnaire Survey Method in Medicine on the Example of Treatment Adherence Scales | Abstract PDF (Eng) similar documents |
| Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich, O. M. Drapkina | ||
| "... to statins in 298 patients with high and very high cardiovascular risk for 3 months. The OS ANTEY assessed ..." | ||
| Vol 15, No 5 (2019) | Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them | Abstract similar documents |
| N. V. Pyrikova, O. N. Antropova, I. V. Osipova | ||
| "... reactions of the cardiovascular system when taking NSAIDs and approaches to their reduction. The article ..." | ||
| Vol 18, No 1 (2022) | The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases" | Abstract similar documents |
| M. V. Zhuravleva, A. V. Panov, A. R. Kuksenok | ||
| "... of Ministry of Health for reduction of cardiovascular mortality in Russia. Material and methods ..." | ||
| Vol 10, No 3 (2014) | THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) | Abstract similar documents |
| M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev | ||
| "... Aim. To evaluate the frequency of the prescription of cardiovascular drugs in patients before ..." | ||
| Vol 19, No 2 (2023) | Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment | Abstract similar documents |
| O. R. Eshmatov, M. S. Khlynin, R. E. Batalov, E. A. Archakov, I. V. Kisteneva | ||
| "... , and adverse clinical events were taken into account. Results. In patients with paroxysmal AF ..." | ||
| Vol 11, No 5 (2015) | Perioperative assessment of troponin level in the non-cardiac interventions: is there such a need? | Abstract similar documents |
| A. N. Sumin | ||
| "... The rate of cardiac events (myocardial infarction, death) in non-cardiac surgery is about 2% to 3 ..." | ||
| Vol 11, No 1 (2015) | ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE | Abstract similar documents |
| M. V. Solodun, S. S. Yakushin | ||
| "... on the achievement of the combined endpoint MACE (Major Adverse Cardiac Events), which included cardiovascular deaths ..." | ||
| Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... with high and very high cardiovascular risk (CVR) in real clinical practice based on the data of the study ..." | ||
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... – arterial hypertension (HT) and hypercholesterolemia (HH) in patients with high risk of cardiovascular ..." | ||
| Vol 10, No 6 (2014) | IХ NATIONAL CONGRESS ON INTERNAL MEDICINE | Abstract similar documents |
| "... Post-event press release. ..." | ||
| Vol 17, No 5 (2021) | Peculiarities of Adverse Events Manifested by Injury of Skin and Skin Derivatives and Associated with Beta-blockers Use | Abstract similar documents |
| A. V. Matveev, E. A. Egorova, E. I. Konyaeva, A. G. Dormidor, E. Yu. Bekirova | ||
| "... of cardiovascular diseases. However, the use of BAB has a number of limitations, first of all, due to adverse drug ..." | ||
| Vol 1, No 1 (2005) | DRUGS AND SMOKING | Abstract similar documents |
| J. V. Lukina | ||
| "... the metabolism of drugs. The number of researches showed decrease in efficacy of some cardiovascular drugs ..." | ||
| Vol 8, No 1 (2012) | THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE | Abstract similar documents |
| V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov | ||
| "... Aim. To estimate in a 12-month study mortality and frequency of recurrent cardiovascular events ..." | ||
| Vol 14, No 5 (2018) | Orthostatic Hypotension: Definition, Pathophysiology, Classification, Prognostic Aspects, Diagnostics and Treatment | Abstract similar documents |
| O. D. Ostroumova, M. S. Cherniaeva, M. M. Petrova, O. V. Golovina | ||
| "... predictor of overall mortality and adverse cardiovascular events. OH is associated with an increased risk ..." | ||
| Vol 19, No 4 (2023) | Biomarkers in predicting mortality from cardiovascular events in patients with heart failure and an implanted cardioverter-defibrillator | Abstract similar documents |
| N. N. Ilov, O. V. Petrova, D. K. Tverdokhlebova, I. R. Karimov, A. A. Nechepurenko, S. A. Boytsov | ||
| "... Aim. To study the role of blood biomarkers in predicting death from cardiovascular events ..." | ||
| Vol 14, No 4 (2018) | Main Approaches to Assessing the Quality of Drug Therapy in Cardiology | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, N. A. Komkova, N. A. Dmitrieva, O. A. Drapkina | ||
| "... important. In the treatment of cardiovascular diseases, medicines that have a proven effect on the outcomes ..." | ||
| Vol 11, No 3 (2015) | PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT | Abstract similar documents |
| A. V. Rudakova | ||
| "... savings as compared with enoxaparin. Apixaban has a maximum capacity for the reduction of VTE events ..." | ||
| Vol 7, No 4 (2011) | SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION | Abstract similar documents |
| S. V. Nedogoda | ||
| "... effects of different medicines. On the basis of presented data author concludes that antihypertensive ..." | ||
| Vol 17, No 1 (2021) | Registration of Medicines in the Soviet Control and Licensing System on the Example of the Cardiological Drug Trinitrolong | Abstract similar documents |
| A. N. Petrenko, P. A. Vasiliev, S. Yu. Martsevich, N. P. Kutishenko, O. I. Zvonareva | ||
| "... -разрешительной системе от авторской идеи до внедрения лекарственного средства в клиническую практику ..." | ||
| Vol 2, No 4 (2006) | QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE? | Abstract similar documents |
| V. V. Iakusevich | ||
| "... also increased recently. According to official data 6-10%of all medicines are counterfeit. Quality ..." | ||
| Vol 9, No 6 (2013) | DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. D. Deev, S. A. Boytsov | ||
| "... of cardiovascular mortality. Improvement of treatment methods is an important aspect in reduction of IHD fatal ..." | ||
| Vol 15, No 5 (2019) | Costs and Evaluation of Vital and Essential Medicines for Internal Diseases Treatment, Purchased by Medical Organizations with the Funding from the System of Obligatory Medical Insurance in 2017 | Abstract similar documents |
| O. M. Drapkina, A. V. Kontsevaya, M. V. Sura, R. N. Shepel, L. M. Zhamalov | ||
| "... Aim. To assess the cost and importance of the vital and essential medicines for the treatment ..." | ||
| Vol 19, No 1 (2023) | Analysis of The Use of PCSK9 Inhibitors in Clinical Practice | Abstract similar documents |
| S. Yu. Volkova, L. A. Boyarskaya, P. Yu. Toropygin, I. A. Morozov, E. A. Boyarskaya | ||
| "... high cardiovascular risk, аccording to long observations in real clinical practice. Material ..." | ||
| Vol 20, No 5 (2024) | Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. E Imaeva, Yu. A Balanova, V. A Kutsenko, A. V Kapustina, V. A Metelskaya, N. A Imaeva, B. M Nazarov, O. E Ivlev, E. B Yarovaya, O. M Drapkina | ||
| "... in relation to cardiovascular events, all-cause and cause-specific mortality and among middle-aged Russian men ..." | ||
| Vol 8, No 2 (2012) | UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE | Abstract similar documents |
| S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev | ||
| Vol 14, No 1 (2018) | COMORBID PATIENT IN GASTROENTEROLOGY: INDIVIDUAL APPROACH | Abstract similar documents |
| I. G. Bakulin, S. A. Sayganov, M. I. Skalinskaya, E. V. Skazyayeva, I. V. Lapinskii | ||
| "... with combination of the digestive and cardiovascular systems disorders. The choice of therapeutic-diagnostic ..." | ||
| Vol 10, No 3 (2014) | EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION | Abstract similar documents |
| "... European Medicines Agency approved apixaban use in cardioversion. ..." | ||
| Vol 16, No 4 (2020) | The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... levels risk of developing cardiovascular complications and chronic kidney disease. The combination ..." | ||
| Vol 18, No 5 (2022) | Assessment of Drug Related Problems and Pharmacist Interventions in Inpatients with Cardiovascular Disease | Abstract PDF (Eng) similar documents |
| S. M. Biradar, B. Kohima, V. Nayak, S. Nandikol, V. Warad, S. M. Byakod, B. S. Hunasagi, S. R. Awasthi | ||
| "... ) and to manifest the role of a pharmacist in ensuring safe and efficient use of medications with cardiovascular ..." | ||
| Vol 17, No 4 (2021) | Assessment of Arterial Stiffness Using the Cardio-Ankle Vascular Index – What We Know and What We Strive for | Abstract similar documents |
| A. N. Sumin, A. V. Shcheglova | ||
| "... of cardiovascular risk, an indicator of arteriosclerosis, and a predictor of cardiovascular events has been ..." | ||
| Vol 5, No 6 (2009) | RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID | Abstract similar documents |
| N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky | ||
| "... events (unstable angina, myocardial infarction, stroke, cardiovascular death) were considered. Results ..." | ||
| Vol 6, No 6 (2010) | REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY" | Abstract similar documents |
| A. A. Aleksandrov | ||
| "... , the effect of combined hypoglycemic therapy on long-term cardiovascular prognosis in patients with type 2 ..." | ||
| Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
| M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
| "... and leads to positive metabolic changes. This results in significant risk reduction of cardio-vascular ..." | ||
| Vol 1, No 3 (2005) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, J. Dallongeville, S. Ebrahim, O. Faergeman, I. Graham, G. Mancia, V. Manger Cats, K. Orth-Gomer, J. Perk, K. Pyorala, J. Rodicio, S. Sans, V. Sansoy, U. Sechtem, S. Silber, T. Thomsen, D. Wood | ||
| "... European guidelines on cardiovascular disease prevention in clinical practice. ..." | ||
| Vol 1, No 2 (2005) | PHARMACOKINETIC RESEARCHES AND PRACTICAL MEDICINE | Abstract similar documents |
| V. G. Belolipetskaya, Y. V. Sukhanov | ||
| "... значимости данной науки как для создания новых лекарственных форм препаратов, так и для подбора оптимального ..." | ||
| Vol 14, No 5 (2018) | Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... data, the type and duration of AF, cardiovascular diseases (CVD), concomitant noncardiac pathology ..." | ||
| Vol 13, No 2 (2017) | OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE | Abstract similar documents |
| E. B. Babanskaya, L. V. Menshikova | ||
| "... ) for the treatment of cardiovascular diseases. Material and methods. A questionnaire survey of 212 doctors (138 ..." | ||
| Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
| L. N. Malay | ||
| "... Statins, the most common drugs for reduction in lipid levels, are “strategic” medicinal products ..." | ||
| Vol 13, No 2 (2017) | THESES OF PSYCHOSOMATIC MEDICINE | Abstract similar documents |
| F. I. Belyalov | ||
| "... frequency of somatic events and hospitalizations in patients with depression. It is important to take ..." | ||
| Vol 16, No 6 (2020) | TRUST Study: Participation in Randomized Controlled Trials and Subsequent Adherence to Visiting Medical Institutions and Taking Medications in Patients with Cardiovascular Diseases. Part II. Assessment of the Quality of Therapy | Abstract similar documents |
| N. O. Vasyukova, N. P. Kutishenko, Yu. V. Lukina, O. I. Zvonareva, S. Yu. Martsevich | ||
| "... Trials on adheRence to Medicines' Intake and regUlar viSits to the docTor) to assess the quality of drug ..." | ||
| Vol 16, No 1 (2020) | High Blood Pressure Variability is an Additional Cardiovascular Risk Factor | Abstract similar documents |
| A. V. Rodionov | ||
| "... that increased BP variability is an independent prognostic factor that increases the risk of cardiovascular ..." | ||
| Vol 6, No 4 (2010) | HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE | Abstract similar documents |
| G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov | ||
| "... The correlation of age-dependent reduction in sex hormones level and changes of cardiovascular ..." | ||
| Vol 16, No 2 (2020) | Off-Label Medicines Use: Complex Problem of Modern Clinical Practice | Abstract similar documents |
| S. R. Gilyarevskiy | ||
| "... World experience in off-label medicines use is presented in the article. Data on the history ..." | ||
| Vol 15, No 2 (2019) | E.I. Chazov and His Role in the Development of the Epidemiology of Cardiovascular Diseases | Abstract similar documents |
| article Editorial | ||
| Vol 13, No 5 (2017) | OFF-LABEL PRESCRIBING. POSSIBLE CAUSES, TYPES AND CONSEQUENCES. LEGAL REGULATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
| S. Yu. Martsevich, A. R. Navasardjan, N. A. Komkova | ||
| "... is broad in various fields of medicine, especially in pediatrics, oncology, obstetrics and gynecology ..." | ||
| Vol 10, No 4 (2014) | RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA | Abstract similar documents |
| T. Vekov | ||
| "... pharmaceutical manufacturers in the application process for inclusion in the positive list of medicines ..." | ||
| Vol 11, No 2 (2015) | AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER | Abstract similar documents |
| V. V. Yakusevich, E. M. Pozdnyakova, Vl. .V. Yakusevich, V. A. Simonov, S. Yu. Martsevich, M. M. Loukianov, A. V. Zagrebelnyy, S. A. Boytsov | ||
| "... Aim. To study the clinical forms of atrial fibrillation (AF), cardiovascular risk factors ..." | ||
| Vol 16, No 1 (2020) | Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice | Abstract similar documents |
| M. M. Loukianov, A. V. Kontsevaya, A. O. Myrzamatova, M. B. Khudyakov, E. Y. Okshina, E. V. Kudryashov | ||
| "... of dapagliflozin in patients with a combination of cardiovascular disease (CVD) and type 2 diabetes in Russian ..." | ||
| Vol 1, No 1 (2005) | MENOPAUSE AND CARDIOVASCULAR RISK | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva | ||
| "... , lipid-lowering and antihypertensive treatment should be considered for cardiovascular risk reduction ..." | ||
| Vol 15, No 4 (2019) | TRUST Study: Participation in Randomized Controlled Trials and Subsequent Adherence to Visiting Medical Institutions and Taking Medications in Patients with Cardiovascular Diseases. Part I. Motives for the Patients' Participation in Clinical Trials | Abstract similar documents |
| S. Yu. Martsevich, N. O. Vasyukova, N. P. Kutishenko, Yu. V. Lukina, O. I. Zvonareva | ||
| "... Trials on adheRence to Medicines' Intake and regUlar viSits to the docTor) and present the first part ..." | ||
| Vol 13, No 5 (2017) | INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION | Abstract similar documents |
| E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash | ||
| Vol 16, No 4 (2020) | Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events? | Abstract similar documents |
| O. L. Barbarash, V. V. Kashtalap, I. A. Shibanova | ||
| "... for practical health care. The positions of one of the components of cardiovascular comorbidity – multifocal ..." | ||
| Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
| "... risk of stroke while tracking clinical events and resulting functional disability. Acute event costs ..." | ||
| Vol 14, No 5 (2018) | Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting | Abstract similar documents |
| A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash | ||
| "... as unfavorable in case of any major adverse cardiovascular events (MACEs) defined as myocardial infarction ..." | ||
| Vol 19, No 4 (2023) | Predictors of recurrent cardiovascular events in patients with a single-vessel coronary artery disease after ST-segment elevation myocardial infarction | Abstract similar documents |
| V. E. Oleynikov, E. V. Averyanova, A. A. Tonkoglaz, M. V. Lukyanova | ||
| "... Aim. To determine the predictors of recurrent cardiovascular events in patients after ST-segment ..." | ||
| Vol 9, No 3 (2013) | INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina | ||
| "... . Relationship between statin therapy and adverse events was evaluated by Naranjo algorithm. Results. Patients ..." | ||
| Vol 14, No 4 (2018) | Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing | Abstract similar documents |
| A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik | ||
| "... prescribing recommendations for AF/DVT patients was 88%. The rate of adverse drug events (ADE) in «non ..." | ||
| Vol 16, No 4 (2020) | From Low-Dose Fixed Combinations for Arterial Hypertension Treatment to Multi-Target Therapy of Cardiovascular Diseases | Abstract similar documents |
| P. A. Lebedev, A. A. Garanin | ||
| "... as the most effective approach to the fight against cardiovascular diseases (CVD). The priority of domestic ..." | ||
| Vol 16, No 1 (2020) | Free medications for treating cardiovascular disease in non-beneficiary patients | Abstract similar documents |
| Article Editorial | ||
| Vol 3, No 3 (2007) | MAXIMAL REDUCTION OF CARDIOVASCULAR COMPLICATIONS RISK – THE MAIN TASK OF MODERN THERAPY FOR HIGH RISK PATIENTS. RANDOMIZED STUDY ON COMPREHENSIVE CONTROL ON ARTERIAL HYPERTENSION AND DYSLIPIDAEMIA | Abstract similar documents |
| N. P. Kutishenko, V. V. Yakusevich, A. A. Seragzim, A. D. Deev, S. Y. Martsevich | ||
| "... Maximal reduction of cardiovascular complications risk – the main task of modern therapy for high ..." | ||
| Vol 7, No 3 (2011) | VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY | Abstract similar documents |
| E. P. Trukhacheva, M. V. Ezhov | ||
| "... . These drugs therapy associates with 30% risk reduction in mortality and coronary events. However , the threat ..." | ||
| Vol 19, No 1 (2023) | The Study of Adherence to Drug Therapy at the Stage of Outpatient Follow-up in Patients with Acute Myocardial Infarction (Data from the PROFIL-IM Registry) | Abstract similar documents |
| E. P. Kalaydzhyan, N. P. Kutishenko, Yu. V. Lukina, D. P. Sichinava, S. Yu. Martsevich, O. M. Drapkina | ||
| "... ) included death from any cause, cardiovascular events (nonfatal myocardial infarction, nonfatal cerebral ..." | ||
| Vol 4, No 3 (2008) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE . | Abstract similar documents |
| I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reimer, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano | ||
| "... Society of Cardiology (ESC), в состав которого входят European Association for Cardiovascular Prevention ..." | ||
| Vol 12, No 3 (2016) | EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
| "... of cardiovascular diseases in patients ≥80 years of age who are the most quickly growing group of population ..." | ||
| Vol 9, No 5 (2013) | THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL | Abstract similar documents |
| A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva | ||
| "... effects were also recorded. Results. A significant reduction in systolic (SBP) and diastolic BP (DBP ..." | ||
| Vol 13, No 1 (2017) | SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION | Abstract similar documents |
| S. N. Bel'diev | ||
| "... Russian physicians often afraid to use statins in patients with high cardiovascular risk ..." | ||
| Vol 9, No 3 (2013) | STATINS AND RISK OF INFECTIOUS DISEASES | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... attention has been paying to statin inducing reduction in bacterial infections incidence and severity ..." | ||
| Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
| S. Yu. Martsevich | ||
| Vol 10, No 5 (2014) | CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE | Abstract similar documents |
| S. V. Gatsura, O. A. Gatsura, A. N. Golosova | ||
| "... antihypertensive agents for initial mono- or combined therapy of mild to moderate HT with moderate cardiovascular ..." | ||
| Vol 18, No 4 (2022) | The Safety of Nicorandil Therapy and the Relationship with Treatment Adherence in Patients with Stable Angina Pectoris (According to the NIKEA Observational Study) | Abstract similar documents |
| Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich | ||
| "... the adverse events (AEs) of nicorandil therapy based on the results of an observational study of NIKEA ..." | ||
| Vol 7, No 3 (2011) | MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE | Abstract similar documents |
| S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko | ||
| Vol 13, No 1 (2017) | EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 | Abstract similar documents |
| L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin | ||
| "... few patients were covered with modern medicines influencing prognosis. AMI hospital treatment ..." | ||
| Vol 17, No 2 (2021) | Clinical Trials Evaluating Drug Therapy: Types, Reliability of Results, Place in Modern Evidence-Based Medicine | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, M. M. Lukyanov, O. M. Drapkina | ||
| "... The article discusses the main methods of evidence in modern medicine. Special attention is paid ..." | ||
| Vol 12, No 1 (2016) | Effect of magnesium on the cardiovascular system in women | Abstract PDF (Eng) similar documents |
| E. A. Ulubieva, A. G. Avtandilov | ||
| "... Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system ..." | ||
| Vol 16, No 6 (2020) | An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? | Abstract similar documents |
| T. V. Pavlova | ||
| "... meta-analyzes reported a reduction of cardiovascular complications in patients treated by rivaroxaban ..." | ||
| Vol 20, No 4 (2024) | Original drugs and generics: are there any differences from the clinician’s point of view? | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, O. M. Drapkina | ||
| "... воспроизведенных лекарственных препаратов (ВЛП), а также эволюция взглядов на доказательства их биоэквивалентности ..." | ||
| Vol 5, No 3 (2009) | RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov | ||
| "... to provide high level of compliance in patients with cardiovascular diseases. ..." | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... in patients with cardiovascular diseases (CVD) and high risk of cardiovascular events (CVE) with indications ..." | ||
| 1 - 100 of 1156 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
